Clinic
North Memorial Health Care
North Memorial Health Care was paid $7.40M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoNORTH MEMORIAL HEALTH CARE
MINNETONKA, MN 55345
MINNETONKA, MN 55345
33aNPI1952732729assigned 12/04/2013
33bProvider typePrimary Care Clinic/Center
28Total paid$7.40M
24GClaims248,381
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Minnesota
Rank by total paid#3 of 72
Median peer was paid$251K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GALE, STEPHANIE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,017 | $8K | |
| 2019 | 3,717 | $140K | |
| 2020 | 3,506 | $138K | |
| 2021 | 5,888 | $222K | |
| 2022 | 95,455 | $3.28M | |
| 2023 | 72,794 | $2.07M | |
| 2024incomplete | 66,004 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 36,687 | 33,877 | $3.14M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 24,766 | 23,041 | $1.52M |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 4.7% | 5,960 | 5,768 | $350K |
| 36415 | Collection of venous blood by venipuncture | 3.0% | 41,718 | 39,418 | $218K |
| 0240U | 2.3% | 1,231 | 1,207 | $173K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 1,587 | 1,554 | $129K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 7,899 | 7,656 | $126K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.6% | 937 | 856 | $119K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 7,654 | 7,458 | $106K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 1,197 | 1,180 | $97K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.0% | 1,106 | 1,033 | $75K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 905 | 882 | $70K |
134 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 451 | $65K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 732 | $58K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 494 | $55K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,877 | $54K |
| T1016 | Case management, each 15 minutes | <1% | 1,750 | $46K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 458 | $45K |
| 80061 | Lipid panel | <1% | 2,974 | $42K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,564 | $42K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 537 | $42K |
| 0054A | <1% | 1,090 | $39K | |
| X5622 | <1% | 234 | $37K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 991 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 988 | $36K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 397 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,132 | $35K |
| 99607 | <1% | 780 | $28K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,056 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,090 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 443 | $22K |
| 80053 | Comprehensive metabolic panel | <1% | 1,921 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,175 | $21K |
| 80050 | General health panel | <1% | 376 | $19K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 206 | $19K |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 595 | $19K |
| 92551 | <1% | 2,559 | $18K | |
| 99606 | <1% | 550 | $18K | |
| 85027 | <1% | 2,756 | $17K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 272 | $16K |
| 86803 | <1% | 988 | $15K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 573 | $15K |
| 90651 | <1% | 178 | $15K | |
| 90682 | <1% | 243 | $13K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 335 | $13K |
| 90686 | <1% | 1,826 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,476 | $13K |
| 96127 | <1% | 3,325 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 750 | $12K |
| 0124A | <1% | 314 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 497 | $9K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,155 | $9K |
| 99385 | <1% | 83 | $8K | |
| 0004A | <1% | 181 | $7K | |
| 87210 | <1% | 1,043 | $6K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,758 | $6K |
| 86780 | <1% | 422 | $6K | |
| 81025 | <1% | 676 | $6K | |
| 90715 | <1% | 240 | $6K | |
| 90677 | <1% | 192 | $6K | |
| 99188 | <1% | 1,278 | $6K | |
| 90750 | <1% | 33 | $5K | |
| 99605 | <1% | 100 | $5K | |
| 91320 | <1% | 39 | $5K | |
| 87081 | <1% | 722 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 569 | $5K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 164 | $5K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 118 | $4K |
| 90480 | <1% | 126 | $4K | |
| 90662 | <1% | 57 | $4K | |
| 84439 | <1% | 439 | $4K | |
| 82607 | <1% | 250 | $4K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 51 | $4K |
| 99173 | <1% | 2,740 | $4K | |
| 82728 | <1% | 260 | $4K | |
| 0052A | <1% | 88 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 350 | $4K |
| 93000 | <1% | 351 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 50 | $3K |
| G0008 | Administration of influenza virus vaccine | <1% | 149 | $3K |
| 84466 | <1% | 224 | $3K | |
| 90670 | <1% | 499 | $3K | |
| 87340 | <1% | 258 | $3K | |
| 81001 | <1% | 754 | $2K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 13 | $2K |
| 17110 | <1% | 27 | $2K | |
| 0051A | <1% | 50 | $2K | |
| 80076 | <1% | 246 | $2K | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 90 | $2K |
| 81003 | <1% | 959 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 27 | $2K |
| 86140 | <1% | 357 | $2K | |
| 82746 | <1% | 117 | $2K | |
| 0001A | <1% | 148 | $2K | |
| 83540 | <1% | 241 | $2K | |
| 80069 | <1% | 184 | $2K | |
| 84403 | <1% | 51 | $1K | |
| 73630 | <1% | 71 | $1K | |
| 85610 | <1% | 284 | $1K | |
| 90656 | <1% | 193 | $1K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 283 | $1K |
| 83013 | <1% | 14 | $949.88 | |
| 85652 | <1% | 320 | $919.15 | |
| 86480 | <1% | 13 | $885.60 | |
| 82043 | <1% | 137 | $846.71 | |
| 83655 | <1% | 60 | $794.67 | |
| 83690 | <1% | 110 | $782.72 | |
| 82570 | <1% | 141 | $775.76 | |
| 82947 | <1% | 190 | $761.30 | |
| 83735 | <1% | 106 | $748.97 | |
| 84481 | <1% | 41 | $748.05 | |
| 85018 | <1% | 291 | $719.38 | |
| 82565 | <1% | 124 | $670.46 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 28 | $568.84 |
| 36416 | <1% | 179 | $552.68 | |
| 73610 | <1% | 27 | $507.64 | |
| 90474 | <1% | 44 | $445.08 | |
| 96161 | <1% | 400 | $425.66 | |
| 95251 | <1% | 13 | $328.51 | |
| 90734 | <1% | 95 | $260.80 | |
| 73130 | <1% | 14 | $222.91 | |
| 84460 | <1% | 39 | $222.28 | |
| 86592 | <1% | 46 | $214.11 | |
| 87338 | <1% | 13 | $202.82 | |
| 82784 | <1% | 15 | $196.04 | |
| 86618 | <1% | 13 | $193.72 | |
| 69209 | <1% | 14 | $186.87 | |
| 84550 | <1% | 36 | $171.42 | |
| 84450 | <1% | 28 | $156.33 | |
| 84480 | <1% | 14 | $134.10 | |
| 90723 | <1% | 315 | $95.02 | |
| 90647 | <1% | 371 | $27.60 | |
| 90633 | <1% | 168 | $0.15 | |
| 90710 | <1% | 133 | $0.05 | |
| 3044F | 0% | 1,539 | $0.00 | |
| 3074F | 0% | 3,982 | $0.00 | |
| 3079F | 0% | 374 | $0.00 | |
| 3075F | 0% | 253 | $0.00 | |
| 90696 | 0% | 43 | $0.00 | |
| 91319 | 0% | 13 | $0.00 | |
| 1160F | 0% | 3,023 | $0.00 | |
| 1159F | 0% | 34,196 | $0.00 | |
| 3078F | 0% | 3,922 | $0.00 | |
| 90681 | 0% | 80 | $0.00 | |
| 90700 | 0% | 13 | $0.00 | |
| 0002A | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGALE, STEPHANIE (INTERIM CFO)
Parent organizationNORTH MEMORIAL HEALTH CARE
| Provider | Location | Paid |
|---|---|---|
| North Memorial Health Care | Brooklyn Center, MN | $112.83M |
| North Memorial Health Care | Robbinsdale, MN | $32.43M |
| Maple Grove Hospital Corporation | Maple Grove, MN | $7.58M |
| North Memorial Health Care | Robbinsdale, MN | $5.62M |
| North Memorial Health Care | Maple Grove, MN | $4.55M |
| North Memorial Health Care | Robbinsdale, MN | $4.03M |
| Oakdale Health Enterprises, INC. | Alexandria, MN | $2.97M |
| North Memorial Health Care | Robbinsdale, MN | $2.19M |
| North Memorial Health Care | Robbinsdale, MN | $1.99M |
| North Memorial Health Care | Maple Grove, MN | $297K |
| Western Physical Therapy INC | Yuba City, CA | $126K |
| North Memorial Health Care | Robbinsdale, MN | $58K |
| Oakdale Health Enterprises INC | Park Rapids, MN | $28K |
| North Memorial Health Care | Robbinsdale, MN | $25K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.